Key result
Hepatitis C virus antibody was present in 15.7% of patients with hypertrophic cardiomyopathy compared with 2.4% of volunteer blood donors.
Patients with hypertrophic cardiomyopathy demonstrated a notably higher prevalence of hepatitis C virus antibodies compared to volunteer blood donors, suggesting a potential association.
Answers are grounded in this paper and cite their sources.
HCV seropositivity may associate with hypertrophic cardiomyopathy; this hypothesis-generating observation leaves open any causal link or screening implications.
Letters1 November 1998Hepatitis C Virus Infection and Hypertrophic CardiomyopathyAkira Matsumori, MD, PhD, Naohiro Ohashi, MD, and Shigetake Sasayama, MD, PhDAkira Matsumori, MD, PhDKyoto University; Kyoto 606, JapanSearch for more papers by this author, Naohiro Ohashi, MDKyoto University; Kyoto 606, JapanSearch for more papers by this author, and Shigetake Sasayama, MD, PhDKyoto University; Kyoto 606, JapanSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-129-9-199811010-00025 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Hypertrophic cardiomyopathy, a family of diseases with genetic and nongenetic causes, occurs throughout the world. It is characterized by morphologically diverse patterns of left ventricular hypertrophy that range from marked diffuse thickening of the ventricular septum and left ventricular free wall to focal hypertrophy of the apical region. An association between hepatitis C virus infection and cardiomyopathies and myocarditis was recently found [1-4].In our study, 11 of 70 (15.7%) patients with hypertrophic cardiomyopathy (mean age of the 70 patients, 57.7 years) were positive for hepatitis C virus antibody compared with 25 of 1039 (2.4%) volunteer blood ...References1. Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation. 1995; 92:2519-25. Google Scholar2. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S. Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun. 1996; 222:678-82. Google Scholar3. Okabe M, Fukuda K, Arakawa K, Kikuchi M. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation. 1997; 96:22-4. Google Scholar4. Matsumori A, Ohashi N, Hasegawa K, Sasayama S, Eto T, Imaizumi T, et al. Hepatitis C virus infection and heart diseases. A multicenter study in Japan. Jpn Circ J. 1998; 62:389-91. Google Scholar5. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y. Giant T-wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasonocardiotomographic study. Jpn Heart J. 1976; 17:611-29. Google Scholar Author, Article, and Disclosure InformationAffiliations: Kyoto University; Kyoto 606, Japan PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByApical Left Ventricular Hypertrophic Cardiomyopathy: A Case ReportEffect of hepatitis B virus infection on right and left ventricular functionsPrevalence of hepatitis C virus infection in patients with cardiomyopathyApical Hypertrophic Cardiomyopathy Mimicking Acute Coronary Syndrome: A Case Report and Review of the LiteratureUsefulness of the Serum KL-6 Assay in Patients with Hepatitis C VirusSjoegren's Syndrome Associated with Chronic Hepatitis C, Severe Thrombocytopenia, Hypertrophic Cardiomyopathy, and Diabetes MellitusHepatitis C and the heart: to beat or not to beatCardiomyopathies and Heart FailureHistopathological and immunohistochemical study of oral lichen planus-associated HCV infectionHepatitis C Virus from the Hearts of Patients with Myocarditis and CardiomyopathyHepatitis C Virus Infection in Hypertrophic or Dilated CardiomyopathyInterferon Treatment for Dilated Cardiomyopathy and Striated Myopathy Associated With Hepatitis C Virus Infection Based on Serial Measurements of Serum Concentrations of Cardiac Troponin THypertrophic Cardiomyopathy as a Manifestation of Cardiac SarcoidosisRole of Hepatitis C Virus in Cardiomyopathies 1 November 1998Volume 129, Issue 9Page: 749-750KeywordsCardiomyopathiesGenetic diseasesHeartHepatitis AHepatitis C virusInfectious hepatitisLeft ventricleMedical risk factorsMyocarditisRNA Issue Published: 1 November 1998 CopyrightCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Akira Matsumori (1998) conducted a letter in Hypertrophic cardiomyopathy (n=1,109). Hypertrophic cardiomyopathy vs. Volunteer blood donors was evaluated on Hepatitis C virus antibody positivity. Hepatitis C virus antibody was present in 15.7% of patients with hypertrophic cardiomyopathy compared with 2.4% of volunteer blood donors.
Synapse has enriched 10 related papers. Consider them for comparative context: